Diagnostics contribute 4% to North American Biological's (NABI) 1994 turnover
This article was originally published in Clinica
Diagnostics products generated sales of $6.2 million for North American Biologicals (NABI), contributing 4% to the blood plasma products manufacturer's 1994 turnover. Diagnostics sales rose 59% compared with 1993, nearly as strongly as group sales which were 62% higher at $164.6 million, partly thanks to an earlier acquisition. Net income in 1994 was $7.9 million, up from $3.5 million in 1993.